Skip to main content
. Author manuscript; available in PMC: 2022 Jan 11.
Published in final edited form as: J Allergy Clin Immunol. 2021 May 24;149(1):410–421.e7. doi: 10.1016/j.jaci.2021.04.036

FIG 1.

FIG 1.

Kaplan-Meier survival curves depicting OS and GFFS for all patients (n = 57) with median follow-up of 27 months overall by the reverse Kaplan-Meier method and 26.3 months (range, 1.5–220.6 months) from first HCT in survivors.